US 7,511,063 B2
High affinity quinoline-based kinase ligands
Yongqi Deng, Newton, Mass. (US); Patrick J. Curran, Winthrop, Mass. (US); Gerald W. Shipps, Jr., Stoneham, Mass. (US); Lianyun Zhao, Burlington, Mass. (US); M. Arshad Siddiqui, Newton, Mass. (US); Janeta Popovici-Muller, Waltham, Mass. (US); Jose S. Duca, Cranford, N.J. (US); Alan W. Hruza, Hackettstown, N.J. (US); Thierry O. Fischmann, Scotch Plains, N.J. (US); Vincent S. Madison, Mountain Lakes, N.J. (US); Rumin Zhang, Edison, N.J. (US); Charles W. McNemar, High Bridge, N.J. (US); Todd W. Mayhood, Randolph, N.J. (US); William T. Windsor, East Brunswick, N.J. (US); Emma M. Lees, Oakland, Calif. (US); and David A. Parry, Mountain View, Calif. (US)
Assigned to Schering Corporation, Kenilworth, N.J. (US)
Filed on Aug. 16, 2006, as Appl. No. 11/504,869.
Prior Publication US 2008/0045568 A1, Feb. 21, 2008
Int. Cl. A61K 31/47 (2006.01); C07D 215/14 (2006.01)
U.S. Cl. 514—314  [546/168] 51 Claims
 
1. A compound of the formula (I)

OG Complex Work Unit Drawing
or a pharmaceutically acceptable salt, solvate or ester thereof, wherein:
R0 is arylalkyl, wherein said aryl is unsubstituted or optionally independently substituted with one or more substituents, which can be the same or different and are independently selected from Q0;
R1 is hydrogen, alkyl, aryl, alkylaryl, arylalkyl, alkylheteroaryl, alkoxy, alkoxyalkyl, alkoxyoxo, amino, aminoalkyl, alkylamino, alkylheterocyclyl, carboxy, cyanoalkyl, cycloalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, hydroxyalkyl, oxo, —CO2R5, —C(O)N(R5)2, or —C═(NOR5), where each of said R5 is independently hydrogen, alkyl, aryl, heteroaryl, heteroarylalkyl, alkylheteroaryl, alkoxyalkyl, aminoalkyl, cyanoalkyl, oxo, cycloalkyl, heterocyclyl, heterocyclylalkyl, alkylheterocyclyl, or alkylamino; further wherein each of said alkyl, aryl, heteroaryl, cycloalkyl and heterocyclyl is unsubstituted or optionally independently substituted with one or more substituents, which can be the same or different and are independently selected from Q1;
R2 is hydrogen, akyl, aryl, alkylaryl, arylalkyl, carboxy, alkoxyoxo, alkylsulfonamido, heterocyclyl, heteroaryl, heteroarylalkyl, —CO2R6, —N(R6)SO2R6, —C(O)NHSO2R6, —SO2R6, —C(O)N(R6)2, or —C(O)NHC(R6)C(O)R6; where each of said R6 is independently hydrogen, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl alkylheteroaryl, alkoxyalkyl, aminoalkyl, cyanoalkyl, alkyloxo, cycloalkyl, heterocyclyl, heterocyclylalkyl, hydroxy, hydroxyalkyl, alkylheterocyclyl, or alkylamino; further wherein each of said alkyl, aryl, heteroaryl, and cycloalkyl and heterocyclyl is unsubstituted or optionally independently substituted with one or more substituents, which can be the same or different and are independently selected from Q2;
R3 is aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, or heteroaryl, further wherein each of said aryl, and heteroaryl, is unsubstituted or optionally independently substituted with one or more substituents, which can be the same or different and are independently selected from Q3;
Q0 is alkyl, hydroxy, amino, halo, alkoxy, alkylamino, dialkylamino, aminoalkyl, hydroxyalkyl, haloalkyl, arylalkyl, heteroarylalkyl, aryl, haloaryl, alkylaryl, aryloxy, heteroaryl, haloheteroaryl, alkylheteroaryl, hydroxyheteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, alkylamido, oxo, alkylsulfonamido, alkyloxo, alkoxyoxo, nitro, cyano, haloalkoxy, —C(O)NH, —NHC(O), —S(O)2NH, or —NHS(O)2;
Q1 is hydrogen, alkyl, hydroxy, amino, halo, alkoxy, alkylamino, dialkylamino, aminoalkyl, hydroxyalkyl, haloalkyl, arylalkyl, heteroarylalkyl, aryl, haloaryl. alkylaryl, aryloxy, cycloalkyl, heteroaryl, haloheteroaryl, alkylheteroaryl, hydroxyheteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, alkylamido oxo, alkylsulfonamido, alkyloxo, alkoxyoxo, nitro, cyano, haloalkoxy-C(O)NH, —NHC(O), —S(O)2NH, or —NHS(O)2;
Q2 is hydrogen, alkyl, alkyloxo, alkylsulfonyl, aryl, arylsulfonyl, hydroxy, hydroxyalkyl, amino, halo, alkoxy, alkoxyoxo, alkylamino, dialkylamino, aminoalkyl, hydroxyalkyl, haloalkyl, arylalkyl, heteroarylalkyl, heteroarylsulfonyl, haloaryl, hydroxysulfonyl, alkylaryl, aryloxy cycloalkyl, heteroaryl, haloheteroaryl, alkylheteroaryl, hydroxyheteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, alkylamido, oxo, alkylsulfonamido, alkyloxo, alkoxyoxo, nitro, cyano, haloalkoxy, —C(O)NH, —NHC(O), —S(O)2NH, or —NHS(O)2; and
Q3 is hydrogen, alkyl, alkylamido, alkyloxo, alkylsulfonyl, alkoxyoxo, alkylaryl, alkylheteroaryl, amino, aryloxy, aryl, arylsulfonyl, alkylsulfonamido, halo, alkoxy, alkoxyoxo, alkylamino, aminoakyl, arylalkyl, cycloalkyl, cyano, dialkylamino, dialkylaminoalkyl, hydroxyalkyl, haloalkyl, haloalkoxy, haloaryl, heteroarylalkyl, heteroarylsulfonyl, hydroxy, hydroxyalkyl, hydroxysulfonyl, heteroaryl, haloheteroaryl, hydroxyheteroaryl, hydroxyheterocyclyl, heteroaryloxy, heterocyclyl, heterocyclyloxy, oxo, nitro, —C(O)NH, —NHC(O), —S(O)2NH, or —NHS(O)2.